Point72 Hong Kong’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-11,300
Closed -$5.13M 570
2022
Q3
$5.13M Buy
11,300
+9,200
+438% +$4.4M 0.18% 140
2022
Q2
$1.01M Buy
2,100
+300
+17% +$148K 0.04% 523
2022
Q1
$884K Sell
1,800
-2,700
-60% -$1.23M 0.03% 553
2021
Q4
$2.09M Sell
4,500
-1,200
-21% -$505K 0.07% 320
2021
Q3
$2.13M Buy
5,700
+2,900
+104% +$1.1M 0.07% 437
2021
Q2
$1.07M Sell
2,800
-4,600
-62% -$1.76M 0.03% 690
2021
Q1
$2.66M Buy
7,400
+4,100
+124% +$1.32M 0.09% 312
2020
Q4
$1.06M Buy
+3,300
New +$1.01M 0.05% 455

Other funds holding ELV

Point72 Hong Kong's ELV Position: Q2 2025 in Review

Point72 Hong Kong sold out of Elevance Health (ELV) in Q2 2025, closing a stake of 4,733 shares — an estimated $2.06M sold.

Point72 Hong Kong first reported a position in ELV in Q4 2014 and held it in 16 quarters. The position peaked at $18.9M in Q4 2023. 1,590 funds tracked by Wall St. Rank hold ELV as of Q2 2025.

  • Point72 Hong Kong reported no remaining Elevance Health position as of Q2 2025 after selling out during the quarter.
  • Point72 Hong Kong sold 4,733 Elevance Health shares in Q2 2025, an estimated $2.06M.
  • Point72 Hong Kong first reported a position in Elevance Health in Q4 2014 and held it in 16 quarters.
  • Point72 Hong Kong's Elevance Health position peaked at $18.9M in Q4 2023.
  • 1,590 funds tracked by Wall St. Rank held Elevance Health as of Q2 2025.

Based on Point72 Hong Kong's 13F filing for Q2 2025, filed 14 Aug 2025.